EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?

Jihyoun Kim iD, Jiaoran Li, Jun Wei, Seon Ah Lim iD

Immune Network · 2025 · 25 (1)

DOI: 10.4110/in.2025.25.e13 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immune Network, 2025. Verfasst von Jihyoun Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Ewha Womans University, Seoul 03760, Korea. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, National Nature Science Foundation of China, Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T (Treg) cells are essential for maintaining immune homeostasis by suppressing excessive immune responses. In the context of cancer, however, Tregs promote immune evasion and tumor progression, particularly through their unique adaptations within the tumor microenvironment (TME). Recent research has emphasized how metabolic characteristics shape Treg activation, migration, and immunosuppressive function, revealing the impact of metabolic pathways on Treg fitness in homeostasis and within the TME. In this review, we first provide an overview of Tregs in cancer immunology, discussing their immunosuppressive roles and properties specific to the TME. We then examine the metabolic requirements for Treg activation and migration under normal conditions, followed by a discussion of how hypoxia, lactate accumulation, nutrient limitation, oxidative stress, and other TME-specific factors alter Treg metabolism and contribute to cancer immune evasion. Finally, we explore therapeutic strategies that target Treg metabolism within the TME, including pharmacological modulation of specific metabolic pathways to diminish Treg-mediated immunosuppression. Thus, we could suggest future directions and clinical implications for Treg-targeted metabolic modulation as a complementary approach in cancer treatment, setting the stage for novel strategies in immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

Immune evasionImmunometabolismImmunotherapyRegulatory T cellTumor microenvironment

Autor:innen und Institutionen

  • Department of Life Science, Ewha Womans University, Seoul 03760, Korea.
  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg…
  • Research Center for Cellular Homeostasis, Ewha Womans University, Seoul 03760, Korea.
  • Multitasking Macrophage Research Center, Ewha Womans University, Seoul 03760, Korea.

ORCID-Profile: Jihyoun Kim, Seon Ah Lim

Förderung

  • National Research Foundation of Korea
  • National Nature Science Foundation of China
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • Distinguished Young Scholars of Tianjin

Zitieren

APA

Kim, J., Li, J., Wei, J., & Lim, S. A. (2025). Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?. Immune Network, 25(1). https://doi.org/10.4110/in.2025.25.e13

Vancouver

Kim J, Li J, Wei J, Lim SA. Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?. Immune Network. 2025;25(1). doi:10.4110/in.2025.25.e13

BibTeX
@article{Kim2025,
  author = {Kim, Jihyoun and Li, Jiaoran and Wei, Jun and Lim, Seon Ah},
  title = {Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?},
  journal = {Immune Network},
  year = {2025},
  volume = {25},
  number = {1},
  doi = {10.4110/in.2025.25.e13}
}
Kostenlos starten →